The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

Glucagon-like peptide-1 (GLP-1) agonist are a family of medications that help manage blood sugar in patients with type 2 ...

Novo Nordisk and Eli Lilly are facing scores of personal injury claims for allegedly failing to warn patients about side ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

The drugs include Mounjaro, also known as tirzepatide, and semaglutide, which is sold under the brand names Wegovy, Ozempic ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

Rybelsus is an oral medication, while Ozempic and Wegovy are injected. Here’s what to know about Rybelsus semaglutide tablets versus injections for weight loss and diabetes. This medication ...

Today it is happening again with GLP1 agonists like Semaglutide with the brand names of Wegovy, Ozempic, and Rybelsus and similar drugs like Moujaro and Zepbound. And just like all the other weight ...

The warning applies to GLP-1 receptor agonists including Ozempic, Wegovy, Rybelsus ... which can be prescribed for diabetes treatment or for weight loss management — have some effects on ...

A surprise amount of Brits say they would take anti-obesity drugs if they were given to them for free on the ...